Mark Lew, MD

Director of the Division of Movement Disorders at the USC Keck School of Medicine

Articles

The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MD

May 23rd 2022

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]

Validating Tears as a Biomarker in Atypical Presentations of Parkinson Disease: Mark Lew, MD

Mark Lew, MD

May 11th 2022

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the efforts needed to validate tears as a biomarker in patients who don’t present with typical Parkinson disease. [WATCH TIME: 4 minutes]

The Future of Tears as a Biomarker for Neurodegenerative Disorders: Mark Lew, MD

Mark Lew, MD

May 9th 2022

The director of the Division of Movement Disorders at the USC Keck School of Medicine provided insight on the next steps in how we can expand on tears as a valuable biomarker for neurodegenerative diseases. [WATCH TIME: 4 minutes]

The Motivations for Using Tears to Confirm Parkinson Disease Diagnosis: Mark Lew, MD

Mark Lew, MD

May 6th 2022

The director of the Division of Movement Disorders at the USC Keck School of Medicine commented on the potential of reflex tears as a critical biomarker of Parkinson disease. [WATCH TIME: 6 minutes]